PharmaCyte Biotech, Inc. (PMCB) Financials
PMCB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Jan. 31, 2026 | 55.9 million | 16.5 million |
| Oct. 31, 2025 | 56.0 million | 19.4 million |
| July 31, 2025 | 45.1 million | 1.5 million |
| April 30, 2025 | 55.2 million | 3.3 million |
PMCB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Jan. 31, 2026 | -786848 | 771516 |
| Oct. 31, 2025 | -979523 | 60492 |
| July 31, 2025 | -2.0 million | 60492 |
| April 30, 2025 | -1.0 million | 63944 |
PMCB Net Income
No data available :(
PMCB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Jan. 31, 2026 | 20.5 million | - | - |
| Oct. 31, 2025 | 15.6 million | - | - |
| July 31, 2025 | 13.4 million | - | - |
| April 30, 2025 | 15.5 million | - | - |
PMCB Shares Outstanding
PMCB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Jan. 31, 2026 | - | 93113 | 2.0 million | - |
| Oct. 31, 2025 | - | 141085 | 1.2 million | - |
| July 31, 2025 | - | 95157 | 753148 | 905680 |
| April 30, 2025 | - | 126734 | 915130 | -905680 |
PMCB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Jan. 31, 2026 | - | - |
| Oct. 31, 2025 | - | - |
| July 31, 2025 | - | - |
| April 30, 2025 | - | - |
PMCB
Price: $0.59
52 week price:
Earnings Per Share: -0.89 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 64200
Market Capitalization: 8.0 million